UCLA scientists have developed an off-the-shelf immunotherapy that may be effective in treating various types of cancer. The therapy has been reported to show promise in targeting ovarian cancer, as well as other solid tumors, although some outlets suggest it may also be applicable to pancreatic, breast, and kidney cancers. The specific types of cancer that can be effectively treated with this immunotherapy are not consistently reported across outlets.